Examination of the additive value of CTC biomarkers of heterogeneity (Het) and chromosomal instability to nuclear-localized (nl) AR-V7+CTCs in prediction of poor outcomes to androgen receptor signaling inhibitor (ARSi) in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Scher, H. I.; Schonhoft, J.; Graf, R. P.; Jendrisak, A.; Barnett, E.; Jayaram, A.; Winquist, E.; Landers, M.; Wang, Y.; Allan, A. L.; Attard, G.; Dittamore, R.
Abstract Title:	Examination of the additive value of CTC biomarkers of heterogeneity (Het) and chromosomal instability to nuclear-localized (nl) AR-V7+CTCs in prediction of poor outcomes to androgen receptor signaling inhibitor (ARSi) in metastatic castration resistant prostate cancer (mCRPC)
Meeting Title:	55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	37
Issue:	15 Suppl.
Meeting Dates:	2019 May 31-Jun 4
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2019-05-20
Start Page:	306s
Language:	English
ACCESSION:	WOS:000487345805482
DOI:	10.1200/JCO.2019.37.15_suppl.5075
PROVIDER:	wos
Notes:	Meeting Abstract: 5075 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/156434